Another thing we love about Noom
Glucagon-like peptide-1 (GLP-1) agonists are injectable weight loss drugs that help people feel fuller and eat less food, leading to weight loss
We, at IntimMedicine Specialist, began work on these agents for weight loss about 12 years ago leading to the original FDA approval of Saxenda for weight control
INDICATIONS : Cardiovascular support Energy enhancement Support neurological function Support for healthy aging Antioxidant supplementation
Key facts about GLP-1 receptor agonist medications Active ingredient: GLP-1 receptor agonists Manufacturer: various manufacturers FDA-approved indication: the GLP-1 class includes drugs FDA-approved for type 2 diabetes (since exenatide in 2005) and for chronic weight management (liraglutide / Saxenda in 2014) Format: available as subcutaneous injection (most products) or oral tablet (Rybelsus only, as of April 2026) List price (April 2026): varies by compound and formulation Where this leaves you If you were searching for GLP-1 receptor agonist medications: they are real, FDA-approved agonists of the glucagon-like peptide-1 receptor (some compounds also engage the GIP receptor
References Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Bhatta L